PODCAST · health
Bridges - Advances in Cancer Therapeutics
by ADC Therapeutics
Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma. With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap and foster collaboration in patient care.This episode is not meant to be used for medical advice and is intended for educational purposes only. Speakers were compensated by ADC Therapeutics for their time. The views expressed in this series do not reflect the views of the speaker's employer. This podcast may include discussion of investigational agents that may not be applicable or approved in your country.
-
4
Episode 4 - Guiding principles when sequencing treatments in DLBCL
Gain practical insights into treatment sequencing in the evolving DLBCL landscape. In this episode, Dr. Marin Xavier shares her approach to navigating novel therapies—such as antibody drug conjugates (ADCs) and bispecifics—with a focus on patients who may not be ready for CAR T-cell therapy. Learn how she makes real-world decisions in a complex and rapidly changing field.Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Marin Xavier, Hematologist and Oncologist, Scripps Health, San Diego
-
3
Episode 3 - Managing novel DLBCL therapies in the community - what good looks like
Integrating novel therapies like bispecific antibodies (BsAbs) and antibody drug conjugates (ADCs) into community oncology practices can be a complex process. On this episode of Bridges, Dr. Lunning and Dr. Graff speak with Dr. Iqra Choudary about how she integrated BsAbs and ADCs into her practice with a proactive multidisciplinary team, strong safety protocols, comprehensive staff training, and strategic hospital partnerships. Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Iqra Choudary, board certified in Internal Medicine, Hematology-Oncology Associates of Central New York
-
2
Episode 2 - The future is now-combination therapies in DLBCL
Interested in novel combination therapies for patients with diffuse large B-cell lymphoma (DLBCL)? Dr. Marie Hu joins the podcast to share her perspectives on emerging treatments and the impact of stronger academic-community collaborations on patient care for relapsed and refractory patients with DLBCL.Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Marie Hu, Assistant Professor of Medicine, University of Minnesota
-
1
Episode 1 - Evolution of Antibody Drug Conjugates
Join us for a high-level look at antibody drug conjugates (ADCs) in lymphoma treatment. Dr. Weiyun Ai provides a detailed overview of ADCs—a pioneering method that can change how lymphoma is treated. Learn how they target cancer, overcome obstacles, and pave the way for developing new combination therapies.Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Weiyun Ai, Professor of Medicine, University of California, San Francisco
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma. With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap and foster collaboration in patient care.This episode is not meant to be used for medical advice and is intended for educational purposes only. Speakers were compensated by ADC Therapeutics for their time. The views expressed in this series do not reflect the views of the speaker's employer. This podcast may include discussion of investigational agents that may not be applicable or approved in your country.
HOSTED BY
ADC Therapeutics
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Bridges - Advances in Cancer Therapeutics have?
Bridges - Advances in Cancer Therapeutics currently has 4 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Bridges - Advances in Cancer Therapeutics about?
Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in...
How often does Bridges - Advances in Cancer Therapeutics release new episodes?
Bridges - Advances in Cancer Therapeutics has 4 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Bridges - Advances in Cancer Therapeutics?
You can listen to Bridges - Advances in Cancer Therapeutics on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Bridges - Advances in Cancer Therapeutics?
Bridges - Advances in Cancer Therapeutics is created and hosted by ADC Therapeutics.
URL copied to clipboard!